EE490 Utilization and Costs of Patients With Type-2 Diabetes and Cardiovascular Disease Treated With Sodium Glucose Cotransporter-2 Inhibitors and Glucagon Like Peptide-1 Receptor Agonists
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2254
https://www.valueinhealthjournal.com/article/S1098-3015(24)02468-9/fulltext
Title :
EE490 Utilization and Costs of Patients With Type-2 Diabetes and Cardiovascular Disease Treated With Sodium Glucose Cotransporter-2 Inhibitors and Glucagon Like Peptide-1 Receptor Agonists
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02468-9&doi=10.1016/j.jval.2024.03.2254
First page :
Section Title :
Open access? :
No
Section Order :
10243